Skip to Main Content (Press Enter)

Logo UNISS
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Competenze

Logo UNISS

|

UNIFIND

uniss.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Competenze
  1. Pubblicazioni

Changes in urinary PGE2 after ibuprofen treatment in preterm infants with patent ductus arteriosus

Articolo
Data di Pubblicazione:
2009
Citazione:
Changes in urinary PGE2 after ibuprofen treatment in preterm infants with patent ductus arteriosus / Antonucci, Roberto; Cuzzolin, L; Arceri, A; Dessì, A; Fanos, V.. - In: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. - ISSN 0031-6970. - 65:3(2009), pp. 223-230.
Abstract:
PURPOSE:
To investigate changes in urinary PGE(2) after ibuprofen treatment in preterm infants with patent ductus arteriosus (PDA).
METHODS:
Twenty preterm infants with a hemodynamically significant PDA (gestational age, 28.6 +/- 2.3 weeks) and 20 controls (gestational age, 30.4 +/- 1.5 weeks) were prospectively enrolled at 48-72 h of life. After enrollment, the former underwent conventional ibuprofen-lysine treatment. At 48-72 h (T(0)) and 108-144 h of life (T(1)), urine samples were noninvasively collected in both groups to measure urinary PGE(2) concentrations (enzyme immunoassay method), and renal function was investigated.
RESULTS:
Urinary PGE(2) decreased significantly both in ibuprofen-treated patients (66.95 +/- 16.78 vs. 27.15 +/- 17.92 pg/mL, P < 0.001) and in controls (71.7 +/- 16.2 vs. 53.2 +/- 18.4 pg/mL, P < 0.001) from T(0) to T(1). However, urinary PGE(2) at T(1) was significantly lower (P < 0.001) in the ibuprofen group compared to the control group. Acute renal failure occurred in three ibuprofen-treated patients (15%).
CONCLUSIONS:
Ibuprofen markedly reduces (59.4%) urinary PGE(2) and may alter renal function in the newborn.
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Antonucci, Roberto; Cuzzolin, L; Arceri, A; Dessì, A; Fanos, V.
Link alla scheda completa:
https://iris.uniss.it/handle/11388/82571
Pubblicato in:
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Journal
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.1.0